These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3715867)

  • 1. Structural basis of gamma-diketone neurotoxicity: non-neurotoxicity of 3,3-dimethyl-2,5-hexanedione, a gamma-diketone incapable of pyrrole formation.
    Sayre LM; Shearson CM; Wongmongkolrit T; Medori R; Gambetti P
    Toxicol Appl Pharmacol; 1986 Jun; 84(1):36-44. PubMed ID: 3715867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence that pyrrole formation is a pathogenetic step in gamma-diketone neuropathy.
    Genter MB; Szakál-Quin G; Anderson CW; Anthony DC; Graham DG
    Toxicol Appl Pharmacol; 1987 Feb; 87(2):351-62. PubMed ID: 3103260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Giant axonopathy characterized by intermediate location of axonal enlargements and acceleration of neurofilament transport.
    Monaco S; Wongmongkolrit T; Shearson CM; Patton A; Schaetzle B; Autilio-Gambetti L; Gambetti P; Sayre LM
    Brain Res; 1990 Jun; 519(1-2):73-81. PubMed ID: 2118823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperbaric oxygen accelerates the neurotoxicity of 2,5-hexanedione.
    Rosenberg CK; Anthony DC; Szakál-Quin G; Genter MB; Graham DG
    Toxicol Appl Pharmacol; 1987 Feb; 87(2):374-9. PubMed ID: 3824391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The spatio-temporal pattern of the axonopathy associated with the neurotoxicity of 3,4-dimethyl-2,5-hexanedione in the rat.
    Anthony DC; Giangaspero F; Graham DG
    J Neuropathol Exp Neurol; 1983 Sep; 42(5):548-60. PubMed ID: 6310058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative neurotoxicity and pyrrole-forming potential of 2,5-hexanedione and perdeuterio-2,5-hexanedione in the rat.
    DeCaprio AP; Briggs RG; Jackowski SJ; Kim JC
    Toxicol Appl Pharmacol; 1988 Jan; 92(1):75-85. PubMed ID: 3341029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. dl- versus meso-3,4-dimethyl-2,5-hexanedione: a morphometric study of the proximo-distal distribution of axonal swellings in the anterior root of the rat.
    Rosenberg CK; Genter MB; Szakál-Quin G; Anthony DC; Graham DG
    Toxicol Appl Pharmacol; 1987 Feb; 87(2):363-73. PubMed ID: 3824390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of 3,4-dimethyl substitution on the neurotoxicity of 2,5-hexanedione. II. Dimethyl substitution accelerates pyrrole formation and protein crosslinking.
    Anthony DC; Boekelheide K; Anderson CW; Graham DG
    Toxicol Appl Pharmacol; 1983 Dec; 71(3):372-82. PubMed ID: 6658787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of 3,4-dimethyl substitution on the neurotoxicity of 2,5-hexanedione. I. Accelerated clinical neuropathy is accompanied by more proximal axonal swellings.
    Anthony DC; Boekelheide K; Graham DG
    Toxicol Appl Pharmacol; 1983 Dec; 71(3):362-71. PubMed ID: 6686353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyrrole oxidation and protein cross-linking as necessary steps in the development of gamma-diketone neuropathy.
    Genter St Clair MB; Amarnath V; Moody MA; Anthony DC; Anderson CW; Graham DG
    Chem Res Toxicol; 1988; 1(3):179-85. PubMed ID: 2979729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in rat axonal cytoskeletal proteins induced by in vitro and in vivo 2,5-hexanedione exposure.
    DeCaprio AP; O'Neill EA
    Toxicol Appl Pharmacol; 1985 Apr; 78(2):235-47. PubMed ID: 3929425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Covalent crosslinking of neurofilaments in the pathogenesis of n-hexane neuropathy.
    Graham DG; Anthony DC; Szakál-Quin G; Gottfried MR; Boekelheide K
    Neurotoxicology; 1985; 6(4):55-63. PubMed ID: 3937075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurofilament protein crosslinking in gamma-diketone neuropathy: in vitro and in vivo studies using the seaworm myxicola infundibulum.
    St Clair MB; Anthony DC; Wikstrand CJ; Graham DG
    Neurotoxicology; 1989; 10(4):743-56. PubMed ID: 2562540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of pyrrole formation in the alteration of neurofilament transport induced during exposure to 2,5-hexanedione.
    Pyle SJ; Amarnath V; Graham DG; Anthony DC
    J Neuropathol Exp Neurol; 1992 Jul; 51(4):451-8. PubMed ID: 1619444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel 2,5-hexanedione analogues. Substituent-induced control of the protein cross-linking potential and oxidation susceptibility of the resulting primary amine-derived pyrroles.
    Xu G; Singh MP; Gopal D; Sayre LM
    Chem Res Toxicol; 2001 Mar; 14(3):264-74. PubMed ID: 11258975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative covalent protein binding of 2,5-hexanedione and 3-acetyl-2,5-hexanedione in the rat.
    DeCaprio AP; Kinney EA; LoPachin RM
    J Toxicol Environ Health A; 2009; 72(14):861-9. PubMed ID: 19557614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanisms of diketone neurotoxicity.
    DeCaprio AP
    Chem Biol Interact; 1985; 54(3):257-70. PubMed ID: 3902259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of in vitro pyrrole adduct autoxidation in 2,5-hexanedione-treated protein.
    DeCaprio AP
    Mol Pharmacol; 1986 Nov; 30(5):452-8. PubMed ID: 3773883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo studies of the molecular pathogenesis of n-Hexane neuropathy.
    Graham DG; Anthony DC; Boekelheide K
    Neurobehav Toxicol Teratol; 1982; 4(6):629-34. PubMed ID: 7170020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro evidence that covalent crosslinking of neurofilaments occurs in gamma-diketone neuropathy.
    Graham DG; Szakál-Quin G; Priest JW; Anthony DC
    Proc Natl Acad Sci U S A; 1984 Aug; 81(15):4979-82. PubMed ID: 6589640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.